Navigation Links
Eularis Announces New Corporate Name and Expanded Product Offerings
Date:9/24/2007

Reshaping Pharmaceutical Analytics Under New Corporate Identity

NEW YORK and LONDON, Sept. 24 /PRNewswire/ -- Campbell Belman, an established pharmaceutical analytics company, today introduces its new name: Eularis. This announcement reflects the significant growth the Company has achieved across its full range of pharmaceutical analytics products, which have helped tailor the advertising and marketing programs of its global top-tier clients, including AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Lilly, Merck, Novo Nordisk and Pfizer.

*(LOGO 72dpi: Send2Press.com/mediaboom/07-0924-Eularis_72dpi.jpg)

Eularis' flagship product, the 94.8 Analytics Process, offers a more mathematically accurate approach to determining the ROI of pharmaceutical marketing by combining up-to-the-minute market data with advanced predictive algorithms. This avoids the inherent flaws of traditional analytics approaches, which rely heavily on historical or analogue data. The 94.8 Analytics Process better accounts for recent changes in the marketplace, allowing companies to better direct marketing and advertising spending to increase revenues and market share.

"The pharmaceutical industry is unique in the level of structural and environmental change it has experienced over the past 20 years. In the current market, where challenges such as product recalls, decline in access to physicians, new restrictions on promotional policy and emergence of legally aggressive generics have come into play, methods that rely on historical data yield reduced accuracy when it comes to predicting future prescribing," commented Dr. Andree K. Bates, president, Eularis. "By collecting current up-to-date market data as part of each individual client's analytics program, Eularis can utilize a snapshot of the current market to avoid the limitations of conventional predictive models and achieve improved accuracy in predicting reactions to promotional activities."

In addition to
'/>"/>

SOURCE Eularis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Biotech firm Replikins Ltd. tod...1N1 virus genomic data. It shows that the lethali...s.d. 4.5) during the virus,s current outbreak in t...his week of 2.0 (s.d. 0.1). The H1N1 infectivity c... Boston (PRWEB) November 27, 2009 -- Bio...
(Date:11/27/2009)... , NEUILLY-SUR-SEINE, France, Nov. 27 /PRNewsw... professional cycling team dedicated to ethical sp...ng champions, announced today that it will become ...itions Optical as a new sponsor of the team. Trans... of adaptive eyewear, offering the most advanced p...
(Date:11/27/2009)... rates to bring unprecedented medical, economic bu...7 (HealthDay News) -- The number of people with di...over the next 25 years, a new study predicts. ,...million people with the disease, up from 23.7 mill...ating people with diabetes will triple, the study ...
(Date:11/27/2009)... Specialist manufacturers who us...s are saving millions of dollars by bringing in te...ss. Increasing numbers of pro-active medical manuf...at the concept stage of their projects, ensuring t...esign processes or potentially outdated technology...
(Date:11/26/2009)...e next 25 years, the number of Americans living wi....7 million in 2009 to 44.1 million in 2034. Over t...riple, rising from $113 billion to $336 billion, e... researchers based at the University of Chicago re... The number of those with diabetes covered by Medi...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
...smart Now the Only Provider to Offer Practice Mana...zes and Types of Mental Health Care Providers, GR...nc.,a leading provider of enterprise-wide software...ale VantageMed,Corporation, a subsidiary of Nighti...
...dings suggest treatment ,holidays, improve quality...(HealthDay News) -- Some men with advanced prostat..., says a study by researchers at the Oregon Health... from the prostate and isn,t affected by the male ...
... COLD SPRING HARBOR, N.Y. Rarely has a book in ...odor Boveris 1914 monograph Concerning the Origin...nd previously almost impossible to track down, the...Concerning the Origin of Malignant Tumours had a ...
...HELL, Wash., Feb. 29 Nastech,Pharmaceutical Compa...ill,host a conference call with investors and secu...m. Eastern time (8:30 a.m. Pacific time) to,discus...901-5259 and international callers should dial (61...
...PHIS, Tenn., Feb. 29 Smith & Nephew,Inc.,s (NYSE:... Business Unit,announced today the appointment of ...ral manager for its business in Asia and Australia...ion, marketing and supply., Durniak,s appointment...
... these side effects are rare and benefits still ou... 29 (HealthDay News) -- Cholesterol-lowering stati...h researchers report. , However, "our series sugge...y Hospital. , Reporting in the March issue of Art...
Other Medicine News:Health News:Netsmart Technologies Acquires Largest Provider of Software for Private Practice Mental Health Providers and Therapists 2Health News:Netsmart Technologies Acquires Largest Provider of Software for Private Practice Mental Health Providers and Therapists 3Health News:Netsmart Technologies Acquires Largest Provider of Software for Private Practice Mental Health Providers and Therapists 4Health News:Chemo Break Benefits Some Men With Prostate Cancer 2Health News:Nastech Pharmaceutical Company Inc. to Hold Conference Call to Discuss Corporate Restructuring and Future Strategy on Monday, March 3, 2008 2Health News:Smith & Nephew Orthopaedic Reconstruction Global Management Team Announced 2Health News:Smith & Nephew Orthopaedic Reconstruction Global Management Team Announced 3Health News:Smith & Nephew Orthopaedic Reconstruction Global Management Team Announced 4Health News:Cholesterol-Lowering Statins Tied to Tendon Woes 2Health News:Cholesterol-Lowering Statins Tied to Tendon Woes 3
(Date:11/25/2009)...INCETON, N.J., Nov. 25 P... pharmaceutical company committed to discovering, ...t viral infections, reported financial results for...ember 30, 2009 Pharmasset held $58.4 million in ca...,, Pipeline Update and 2009 Highlights ,, ...
(Date:11/25/2009)...GEWATER, N.J., Nov. 25 The FDA gra...avirine) tablets, a non-nucleoside reverse transcr...RTI specifically indicated for use in treatment-ex...ilure with HIV-1 strains resistant to an NNRTI and...al approval is based on 48-week data from two Phas...
(Date:11/25/2009)...SKING RIDGE, N.J., Nov. 25 Regado ...development of antithrombotic aptamers with active...CEO and President, will be presenting at the Piper... New York Palace Hotel in New York City. Dr. Mazz...Tuesday, December 1 and will include an overview o...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Electrocardiogram Blip Signals Heart Trouble 49820 1Electrocardiogram Blip Signals Heart Trouble 49820 2Electrocardiogram Blip Signals Heart Trouble 49820 3Connextions Inc Strengthens Technology Capabilities with Addition of Highly Regarded IT Executive 49816 1Connextions Inc Strengthens Technology Capabilities with Addition of Highly Regarded IT Executive 49816 2Connextions Inc Strengthens Technology Capabilities with Addition of Highly Regarded IT Executive 49816 3Children 26apos 3Bs National Medical Center Honors The Children 26apos 3Bs Cancer Foundation for Commitment to Area Kids 49812 1Children 26apos 3Bs National Medical Center Honors The Children 26apos 3Bs Cancer Foundation for Commitment to Area Kids 49812 2Children 26apos 3Bs National Medical Center Honors The Children 26apos 3Bs Cancer Foundation for Commitment to Area Kids 49812 3
...ppoints Director, Clinical Operations and Manager,...tar LLC, (Cellectar), a,privately-held radiopharma...ts to detect, treat and monitor human cancers, tod...rector, Clinical Operations and LisaAnn,Trembath a...eflect the,advancement of the company,s lead produ...
...NCETON, N.J., Oct. 3 Pharmasset, Inc.,(Nasdaq: V...7128 in,combination with Pegasys (pegylated interf...nt-naive patients chronically infected with hepati...f PSI-6130, an oral cytidine,nucleoside analog pol...hrough Pharmasset,s collaboration with Roche. The ...
Other Medicine Technology:Cellectar Expands Clinical Management Team 2Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C 2Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C 3Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C 4Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C 5
Sterile Coil Packed Suction Catheters with SAFE-T-VAC Valve
Tracheal Suction Plastic Catheters
Aviso A/B
... an affordable full-field, autoperimeter that incl...by at least 40%. It has a small footprint and is r...and easy two-button operation making it not only p...D 400 FT is the workhorse of the Paradigm family o...
Medicine Products: